MIRM

MIRM R&D to Revenue

35.71%Fiscal year

Period ending:

MIRM FY R&D/Revenue%
MIRM FY R&D/Revenue769.15%-82.41%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

MIRM r&d to revenue history

R&D spending as percentage of revenue. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Mirum Pharmaceuticals Inc R&D to Revenue — Annual fiscal periods
Period endingR&D to Revenue
35.7134%
41.7438%
55.0554%
138.6442%
686.7384%
0%
0%
0%

Compare r&d to revenue

All MIRM financial metrics · MIRM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.